mTORC1-Dependent Protein and Parkinson’s Disease: A Mendelian Randomization Study

Background: The mTOR pathway is crucial in controlling the growth, differentiation, and survival of neurons, and its pharmacological targeting has promising potential as a treatment for Parkinson’s disease. However, the function of mTORC1 downstream proteins, such as RPS6K, EIF4EBP, EIF-4E, EIF-4G,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Cheng, Ai, Jianzhong, Zhu, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137243/
https://www.ncbi.nlm.nih.gov/pubmed/37190500
http://dx.doi.org/10.3390/brainsci13040536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137243/
https://www.ncbi.nlm.nih.gov/pubmed/37190500
http://dx.doi.org/10.3390/brainsci13040536

Ejemplares similares